🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› USA
Clinical trial register · United States · industry-sponsored

Industry-sponsored studies with a US investigative site

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9112 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 23 Sep 2026, 03:16 UTC
9112
Studies in scope
industry-sponsored, all four open statuses
4950
Recruiting now
open to new participants
2202
Lead sponsors
across recruiting studies
Top states
California 5295 Florida 4397 Illinois 2479 Georgia 2346 Arizona 2231
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca299 Novartis Pharmaceuticals202 Eli Lilly and Company190 Merck Sharp & Dohme LLC183 AbbVie172
State
California5295 Florida4397 Illinois2479 Georgia2346 Arizona2231
All 51 states
Target enrolment
to
9112 of 9112 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
NCT07441395Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema, Eczema, Atopic
Corvus Pharmaceuticals, Inc.
Phase 2
200
California
2026-02
Recruiting
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
NCT07402876Primary Vitreoretinal Lymphoma
Aldeyra Therapeutics, Inc.
Phase 3
20
Florida
2026-02
Not yet open
Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
NCT07328542Hypogonadism, Male
Azurity Pharmaceuticals
Phase 4
144
Alabama, Florida, New York, Texas, Utah
2026-02
Recruiting
Flourish: Exploring the Early Infant Gut Microbiome
NCT07333482Microbiota, Gut Microbiome, Eczema, Microbiome
Seeding Inc
Not applicable
250
Texas
2026-01-31
Recruiting
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
NCT07403552Healthy
Ensho Therapeutics, Inc.
Phase 1
24
California
2026-01-31
Not yet open
Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease
NCT07315984Huntington Disease
BioSensics
Observational
75
New York, Tennessee
2026-01-31
Not yet open
Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris
NCT06729450Acne Vulgaris on the Face
Kane Biotech Inc
Not applicable
24
Florida
2026-01-30
Recruiting
Effectiveness of the SoundHeal Multi-Sensory Integrative Therapy Among Justice-Involved Youth
NCT07364799Emotional Dysregulation, Therapeutic Alliance, Depression Disorder, Anxiety Disorders
SoundHeal
Not applicable
12
California
2026-01-30
Active, closed
Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries
NCT07080008Ureter Injury
MediBeacon
Phase 1
10
Missouri
2026-01-30
Recruiting
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
NCT06594393Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa
Xinnate AB
Phase 2
32
Ohio
2026-01-30
Recruiting
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
NCT07080385Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company
Phase 2/3
28
Connecticut, District of Columbia, Florida, Pennsylvania
2026-01-30
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
NCT07288177Non-small Cell Lung Cancer (NSCLC)
Genmab
Phase 2
240
California, District of Columbia, Florida, Georgia, Montana, Nebraska, New Jersey, New York
2026-01-30
Not yet open
Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The "CAT5-GS" Study
NCT07312006Pain, Postoperative
SurgiQuest, Inc.
Not applicable
74
Florida
2026-01-30
Recruiting
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
NCT07397338Advanced Solid Tumors, Metastatic Solid Tumors, Non-small Cell Lung Cancer (NSCLC), NSCLC
Revolution Medicines, Inc.
Phase 1/2
370
California, Connecticut, Minnesota, Tennessee, Texas, Virginia
2026-01-30
Recruiting
A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
NCT07258407Metastatic Castration-Resistant Prostatic Cancer
T.O.A.D. Oncology SA
Phase 1/2
180
Connecticut
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Arkansas, California, Colorado, Florida, New Jersey, New York, Oregon, Texas
2026-01-30
Not yet open
Evaluation of SPM™ Topical Cosmetic Application on Skin Appearance, Hydration, and Barrier Support in Healthy Adults
NCT07236736Healthy Skin, Skin Hydration
Biocoz Global Pte. Ltd.
Not applicable
10
California
2026-01-30
Recruiting
Decentralized Study to Evaluate a Dietary Supplement for Episodes of Mild Acute Stress in Healthy People
NCT07511088Situational Anxiety
PLT Health Solutions
Not applicable
250
California
2026-01-29
Recruiting
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946Non-Hodgkin Lymphoma Refractory/ Relapsed, DLBCL - Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma (MCL), Follicular Lymphoma ( FL)
LTZ Therapeutics, Inc.
Phase 1
42
California, Missouri, New York, Tennessee, Washington
2026-01-29
Active, closed
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
NCT07363720Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
Takeda
Phase 3
98
California, Florida, Michigan, New Jersey, North Carolina, Ohio, South Carolina, Texas
2026-01-29
Recruiting
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
NCT06875128Metastatic Breast Cancer in the Liver
Delcath Systems Inc.
Phase 2
90
Florida, Ohio, Texas
2026-01-29
Recruiting
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP
NCT07024316Congenital Erythropoietic Porphyria (CEP)
Atlas Molecular Pharma
Phase 1/2
6
Ohio
2026-01-29
Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
NCT07227597Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC
Phase 1/2
170
California, Colorado, Florida, Kentucky, Missouri, New Jersey, Oregon, South Dakota
2026-01-29
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
NCT07288567Schizophrenia
Bristol-Myers Squibb
Phase 3
166
California, Florida, Georgia, Illinois, Massachusetts, New York, Ohio, Tennessee
2026-01-29
Active, closed
Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
NCT07505004Focal Epilepsy
Praxis Precision Medicines
Phase 3
300
Florida, New Jersey, New York, North Carolina, Texas
2026-01-29
Recruiting
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
NCT07428538Hepatitis
Bausch Health Americas, Inc.
Phase 3
350
Alabama, Arizona, California, Connecticut, District of Columbia, Florida, Georgia, Illinois
2026-01-29
Recruiting
A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.
NCT07290790Malocclusion
Dentsply Sirona Implants and Consumables
Not applicable
90
California, New Jersey, North Carolina, Texas
2026-01-29
Recruiting
tAN for Substance Use Disorder
NCT07281261Alcohol Use Disorder, Alcohol Abuse, Substance Use Disorders, Substance Use Disorders Alcohol Use Withdrawal State
Spark Biomedical, Inc.
Not applicable
20
Texas
2026-01-28
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
NCT07323654Eosinophilic Asthma
Kymera Therapeutics, Inc.
Phase 2
264
California, Colorado, Connecticut, Florida, Georgia, Iowa, Kansas, Kentucky
2026-01-28
Recruiting
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
NCT07315360Renal Impairment, Healthy
Pfizer
Phase 1
28
California, Florida, Minnesota
2026-01-28
Recruiting
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
NCT07225621Glioblastoma, GBM
Alpheus Medical, Inc.
Phase 2
103
Massachusetts, Minnesota, New York, Ohio, Pennsylvania
2026-01-28
Recruiting
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
NCT07439887Stargardt Disease
Ray Therapeutics, Inc.
Phase 1/2
18
California, Pennsylvania, Texas
2026-01-28
Recruiting
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
NCT07252479Solid Tumors (Phase 1), RAS Mutation
Adlai Nortye Biopharma Co., Ltd.
Phase 1
118
Florida, Texas
2026-01-28
Recruiting
Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.
NCT07665268Skin Ulcer, Pressure Ulcer (PU), Pressure Ulcer of Skin, Pressure Sore
Sequence LifeScience, Inc.
Phase 4
2,000
Ohio
2026-01-28
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
NCT07154823Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
Tempus AI
Observational
550
Iowa, Maryland, Missouri, Nevada, North Carolina, Ohio, Pennsylvania, South Dakota
2026-01-27
Active, closed
A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers
NCT07223333Type 2 Diabetes
AdipoPharma LLC
Phase 1
56
Ohio
2026-01-27
Recruiting
Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
NCT07310290Migraine
AbbVie
Observational
189
California, Illinois, Nebraska
2026-01-27
Recruiting
Flow Detection in Open and Closed Shunt Valve Periods
NCT07478926Hydrocephalus
Rhaeos, Inc.
Not applicable
55
Illinois
2026-01-27
Recruiting
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07259317Adenocarcinoma, Carcinoma, Pancreatic Ductal
Corcept Therapeutics
Phase 2
80
Arizona, California, Georgia, Indiana, Kansas, Michigan, New Jersey, New York
2026-01-27
Recruiting
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
NCT07336446Prostate Cancer
AstraZeneca
Phase 1/2
300
California, Florida, Massachusetts, Missouri, South Carolina, Tennessee, Utah
2026-01-27
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07219212Squamous Cell Carcinoma of Head and Neck
Johnson & Johnson Enterprise Innovation Inc.
Phase 1
45
Alabama, California, Florida, Georgia, Massachusetts, New York, North Carolina, Pennsylvania
2026-01-26
Active, closed
Effects of a Topical Serum Solution on Hair Characteristics
NCT07785869Hair Characteristics
Pacagen, Inc.
Not applicable
190
New Jersey, Virginia
2026-01-26
Recruiting
Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction
NCT07273773Erectile Dysfunction (ED)
Rigicon, Inc.
Not applicable
182
Florida, Georgia, Texas
2026-01-26
Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
NCT07287917Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
Aminex Therapeutics, Inc.
Phase 1/2
92
Arizona, California, Colorado, Kansas, Michigan, Minnesota, New York, Ohio
2026-01-26
Recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263Hidradenitis Suppurativa
Takeda
Phase 2
90
Arizona, Arkansas, California, Florida, Massachusetts, Michigan, New Hampshire, New York
2026-01-26
By invitation
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
NCT07286006Graves' Disease
Immunovant Sciences GmbH
Phase 2
372
Arizona, California, Colorado, Delaware, District of Columbia, Florida, Georgia, Indiana
2026-01-26
Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07015190Uveal Melanoma
IDEAYA Biosciences
Phase 3
520
Arizona, California, Colorado, Florida, Maryland, Massachusetts, Michigan, Minnesota
2026-01-25
By invitation
Mobile Behavioral Activation Program With Wearable Sensors and Secure Activity Verification
NCT07382804Health Behavior, Behavioral Activation, Sedentary Behavior
Truway Health, Inc.
Not applicable
227,000
New York
2026-01-25
Recruiting
MyVitalC: Sleep and Everyday Headache Management
NCT07477236Sleep, Headaches
Efforia, Inc
Not applicable
100
New York
2026-01-24
Active, closed
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
NCT07357415Obesity, Overweight
Eli Lilly and Company
Phase 3
600
Arizona, California, Florida, Hawaii, Kentucky, Massachusetts, Michigan, New York
2026-01-24
Recruiting
A First-in-Human Single and Multiple Ascending Dose Study of MT-251
NCT07423299Healthy Volunteers
Mirador Therapeutics, Inc.
Phase 1
70
California
2026-01-23
Recruiting
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
NCT07230288Idiopathic Pulmonary Fibrosis
AbbVie
Phase 2
165
Alabama, Florida, Illinois, Michigan, Missouri, Pennsylvania, Virginia
2026-01-23
Recruiting
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
NCT07494305Bipolar I Disorder
LB Pharmaceuticals Inc.
Phase 2
320
Arkansas, California, Florida, Georgia, Illinois, Michigan, Missouri, Nevada
2026-01-23
Recruiting
Drug-Drug Interaction Study of ABP-671 in Gout Patients
NCT07367971Gout Chronic, Gout, DDI (Drug-Drug Interaction)
Atom Therapeutics Co., Ltd
Phase 1
20
North Carolina
2026-01-23
Recruiting
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
NCT07184619Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA
Phase 3
400
California, Florida, Georgia, Maryland, New York
2026-01-23
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
NCT07277231Chronic Lymphocytic Leukemia
BeOne Medicines
Phase 3
500
California, Colorado, Florida, Illinois, Louisiana, Massachusetts, Minnesota, Nebraska
2026-01-22
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
NCT07096778Multiple Myeloma Refractory, Multiple Myeloma in Relapse
CellCentric Ltd.
Phase 2
100
Arizona, California, Florida, Georgia, Illinois, Iowa, Maryland, Massachusetts
2026-01-22
Recruiting
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
NCT07159841Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.
Phase 2/3
153
California, Massachusetts, Michigan, Minnesota, New Jersey, New York, Pennsylvania, Texas
2026-01-22
Active, closed
Radicle Clarity DSTTM: A Study Assessing the Impact of Health and Wellness Products on Mental Clarity and Related Health Outcomes
NCT07342192Cognitive Function
Radicle Science
Not applicable
990
California
2026-01-22
Active, closed
RPMO2 Oximeter Accuracy During Sleep 1 Trial
NCT07397780Obstructive Sleep Apnea
ProSomnus Sleep Technologies
Observational
30
Texas
2026-01-22
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184944Crohn's Disease
Sanofi
Phase 3
751
Colorado, Florida, Indiana, Louisiana, Missouri, New York, North Carolina, Ohio
2026-01-22
Recruiting
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
NCT07332091Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
CSL Behring
Phase 2
84
Arizona, California, Florida, Indiana, Louisiana, Maryland, Michigan, Minnesota
2026-01-22
Active, closed
A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia
NCT07251465Community-Acquired Pneumonia (CAP)
Pfizer
Observational
846,279
New York
2026-01-21
Not yet open
Clinical Accuracy Validation of the Moni-Patch Temperature Monitoring Patch System
NCT07397078Body Temperature, Febrile
Murata Vios, Inc.
Not applicable
105
Minnesota
2026-01-21
Recruiting
AI-driven Total Parenteral Nutrition Platform
NCT07414576Intestinal Failure
Takeoff41, Inc.
Not applicable
260
California
2026-01-21
Recruiting
Sleep and Morning Wellbeing Study
NCT07311434Sleep, Relaxation, Stress, Daytime Sleepiness
Athletic Greens International
Not applicable
300
California
2026-01-20
Recruiting
A Study to Evaluate the Effect of KarXT on Urological Safety
NCT07221877Schizophrenia
Bristol-Myers Squibb
Phase 4
60
Arkansas, California, Florida, Illinois, Nevada, New Jersey, Pennsylvania, Texas
2026-01-20
Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
NCT07359846Severe Asthma
Generate Biomedicines
Phase 3
786
California, Florida, Massachusetts, Michigan, New York, Ohio, Oklahoma, South Carolina
2026-01-20
Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
NCT07262619Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer, MSI-H/dMMR Colorectal Cancer
Eikon Therapeutics
Phase 1/2
160
California, Florida, New Jersey, New York, Texas
2026-01-20
Recruiting
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
NCT07348692Pneumococcal Immunization, Healthy Volunteers
Sanofi
Phase 3
2,195
Arkansas, California, Florida, Kentucky, Michigan, South Carolina, Texas, Utah
2026-01-20
Active, closed
Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes
NCT07408518Digestive Disease, Gut Health
Synbiotic Health
Not applicable
92
California
2026-01-20
Recruiting
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
NCT07282743Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited
Phase 2
285
Arkansas, Florida, Kansas, Oklahoma
2026-01-20
Recruiting
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
NCT07263594Gastrointestinal Cancer
DualityBio Inc.
Phase 1/2
127
Florida, Michigan, North Carolina, Ohio
2026-01-20
Recruiting
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
NCT07247188Sickle Cell Disease
Sanofi
Phase 3
100
Georgia, Nebraska, New Jersey, Texas
2026-01-20
Active, closed
To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.
NCT07369362Infertility, Male Infertility, InVitro Fertilization, Aneuploidy Rate
MotilityCount aps
Not applicable
1,600
Connecticut
2026-01-20
Active, closed
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
NCT07230860Dermatitis, Atopic
Janssen Research & Development, LLC
Phase 2
189
California, Florida, Illinois, Indiana, Michigan, North Dakota, Oregon, Pennsylvania
2026-01-20
Recruiting
Evaluation of Gut-Related Well-Being and Mood Effects of a Daily Nutritional Food Ingredient From the Co-Fermentation of Fungal Mycelium (Pleurotus Pulmonarius) and Microalgae (Chlorella Vulgaris)
NCT07407777Gastrointestinal Discomfort, Digestive Well Being, Gut-related Symptoms
Koralo GmbH
Not applicable
80
California
2026-01-19
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
NCT07216703Cervical Cancer
Merck Sharp & Dohme LLC
Phase 3
1,023
Alabama, Florida, Georgia, Louisiana, Maryland, Minnesota, Nevada, New York
2026-01-19
By invitation
Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use
NCT07311889Postoperative Pain, Postoperative Edema, Postoperative Ecchymosis, Surgical Wound Healing
Elixir MD Inc
Observational
300
California
2026-01-19
Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
NCT07226661Major Depressive Disorder (MDD)
Supernus Pharmaceuticals, Inc.
Phase 2
230
California
2026-01-19
Recruiting
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
NCT07230834Geographic Atrophy (GA)
Regeneron Pharmaceuticals
Phase 1
54
Colorado, Massachusetts, Texas
2026-01-19
Active, closed
A Randomized, Placebo Controlled Trial of L Max in Healthy Adult Athletes
NCT07102680Healthy Normal Athletes
Climatic, Inc.
Not applicable
120
California
2026-01-19
Recruiting
Prospective HemorrhoIdaL EmboliSation (PILES) Registry
NCT07635784Hemorrhoid, Internal Hemorrhoids, Hemorrhoid Bleeding, Hemorrhoidal Bleeding
Joint & Vascular Institute
Observational
1,200
Illinois
2026-01-18
Recruiting
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
NCT07408219Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Observational
350
New Jersey
2026-01-17
Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
NCT07195695Non-small Cell Lung Cancer
Boehringer Ingelheim
Phase 3
400
California, District of Columbia, Florida, Georgia, Idaho, Illinois, Massachusetts, Nevada
2026-01-16
Recruiting
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
NCT06594068Systemic Lupus Erythematosus
AstraZeneca
Phase 4
16
Nevada
2026-01-16
Recruiting
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
NCT07220616Hematological Malignancies, B-cell Non-Hodgkin Lymphoma
Daiichi Sankyo
Phase 1/2
420
New York
2026-01-16
By invitation
Examining the Impact of a Digital Health Program and TENS Device for Patients With Chronic Low Back Pain
NCT07011537Back Pain Lower Back Chronic, Chronic Pain, Musculoskeletal Pain
Hinge Health, Inc
Not applicable
196
Minnesota
2026-01-16
Recruiting
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
NCT07235293Colorectal Cancer
Kahr Bio Australia Pty Ltd
Phase 2
90
Colorado, Florida, North Carolina, Pennsylvania, Texas
2026-01-16
Recruiting
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
NCT07114718Congenital Heart Disease, Congenital Heart Disease (CHD)
Starlight Cardiovascular Inc
Not applicable
45
California, Colorado, Massachusetts, Ohio, Pennsylvania, Texas, Washington
2026-01-16
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07185009Ulcerative Colitis
Sanofi
Phase 3
751
Arizona, California, Colorado, Florida, Indiana, Louisiana, Michigan, Missouri
2026-01-16
Recruiting
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
NCT07053800Lupus Nephritis
Autolus Limited
Phase 2
35
New York, Texas
2026-01-16
Recruiting
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
NCT07276373Neoplasms
Corcept Therapeutics
Phase 1/2
50
California, Illinois, Michigan, Texas, Utah
2026-01-16
Active, closed
Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users
NCT07571148Schizophrenia
Bristol-Myers Squibb
Observational
6,876
Illinois
2026-01-16
Recruiting
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
NCT07321873Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 2
240
Arkansas, California, Florida, Georgia, Illinois, Indiana, New Mexico, North Carolina
2026-01-15
Active, closed
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
NCT07308847Paroxysmal AF
Medtronic Cardiac Ablation Solutions
Not applicable
300
Arkansas, California, Florida, Georgia, Illinois, Kansas, Massachusetts, Minnesota
2026-01-15
Not yet open
Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
NCT07226830Myasthenia Gravis Generalized
BioSensics
Observational
25
Massachusetts
2026-01-15
Recruiting
A Study of LY4515100 in Healthy Participants
NCT07339722Healthy
Eli Lilly and Company
Phase 1
123
Texas
2026-01-15
Not yet open
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
NCT07222813Heart Failure, Heart Failure - NYHA II - IV
Echosens
Not applicable
149
California, Minnesota, South Carolina, Texas
2026-01-15
By invitation
A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
NCT07262268Familial Erythromelalgia
Biohaven Therapeutics Ltd.
Phase 1
5
Connecticut
2026-01-15
Rows per page Showing 1801–1900 of 9112
Previous 17 18 19 20 21 Next
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-usa?page=19

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →
→

Browse trials by condition

Advanced Solid Tumor (143) Breast Cancer (139) Obesity (123) Multiple Myeloma (109) Advanced Solid Tumors (89) Colorectal Cancer (83) Solid Tumor (81) Overweight (77) Ovarian Cancer (74) Healthy (73) Prostate Cancer (73) Heart Failure (72) Non-Small Cell Lung Cancer (70) Cancer (65) Melanoma (63)
→

Browse trials by state

California (5295) Florida (4397) Illinois (2479) Georgia (2346) Arizona (2231) New York (2126) Colorado (2066) Texas (1969) Massachusetts (1836) Michigan (1481) Alabama (1288) Connecticut (1274) Maryland (1267) Ohio (1252) Indiana (1114)
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.